New Sleep Apnea Treatment Trial

Sommetrics is now enrolling subjects who cannot use CPAP for the US clinical trial of its non-invasive aerSleep® II device for treating sleep apnea.

Study Objective

To determine the safety and effectiveness of the aerSleep® II device for treatment of moderate to severe Obstructive Sleep Apnea (OSA) over 24 weeks of home use in spontaneously breathing adults who are intolerant of Continuous Positive Airway Pressure (CPAP) therapy.

Up to 200 participants will be enrolled at ten study sites in the states of Arizona, Florida, Ohio, Pennsylvania, and South Carolina to ensure that approximately 79 subjects who are termed initial responders can be evaluated over 24 weeks. Prior to starting, subjects will have tests for eligibility and device fit/comfort. Sleep assessments of OSA, for continuation in the trial and to assess the effects of therapy, will be performed using home sleep tests.

Additional information can be found on the website at:

Title: Study Using Negative Pressure to Reduce Apnea (SUPRA)

Further information on Sommetrics and its aerSleep® technology can be found at